Clinical Pharmacology Details


TICLOPIDINE


View Drug Forms

Indications & Dose:

Reducing the risk of thrombotic stroke in aspirin intolerant patients or aspirin failures; prevention of thrombosis following intra coronary stent placement*; intermittent claudication*; chronic arterial occlusion*; sickle cell disease


BY MOUTH


Adults 250mg twice daily with food.


Children Not recommended


 

Contraindications:

Current blood dyscrasia (neutropenia, thrombocytopenia); history of TTP; hemostatic disorder or active pathological bleeding (such as being peptic ulcer or intracranial bleeding); patients with severe liver impairment 

Side Effects:

GI (40% have GI effects): Cholestatic jaundice,diarrhea, Gf discomfort, hepatitis; increasedcholesterol, LDL, VLDL; nausea, vomiting


HEME: Agranulocytosis, bleeding (epistaxis,hematuria, conjunctival hemorrhage, GI bleeding),neutropenia, thrombocytopenia


SKIN: Pruritus, rash


 

Cautions:

Precautions:

Past liver disease, renal disease, elderly, children, increased bleeding risk (trauma, surgery, or pathological conditions, dental procedures)


Pregnancy ; use caution in nursing mothers


 

Interaction:

Drugs


Cyclosporine: Potential for reduction in blood cyclosporine concentrations


Phenytoin: Inhibition of hepatic metabolism of phenytoin; potential for development of phenytoin toxicity, reduction in phenytoin dose may be necessary


Theophylline: Increased theophylline level via inhibition of metabolism, increased risk of toxicity


 

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: